I tried to tie it back to the possibility of someone, maybe big pharma, exerting influence to suppress the connection between Tempol and Adamis in order to prevent spikes in PPS which could give Carlos a stronger negotiating position in a potential acquisition situation. I consider the mere mention of potential acquisition to be a positive (for both of my two favorite stocks).
Without some possible justification as to WHY they seem to remain anonymous while Tempol is getting some great press, it would seem to only be negative. That CNBC article could have bumped us up substantially if they had mentioned the company, but nooo... their identity remains suppressed. And if there is no legitimate, viable reason for the company to fly so far under the radar screen while moving forward with a groundbreaking, life-saving treatment for the most severe pandemic in modern history, well then I guess that would be a negative. I consider that to be intuitively obvious so I try not to harp on it too much, and instead point out the less obvious possible explanation which would be absolutely, wonderfully positive if it (acquisition) turned out to be the correct answer.
Message in reply to:
Back on 6/3/21 I mentioned this lack of connection between Tempol and ADMP in my post 2628 and was told I was being negative. Fast forward over 2 months, I agree with you on this point.
ShortsRClowns Thursday, 06/03/21 05:12:29 PM
Re: OR Nurse post# 2626 0
Post # of 3109
Is it me or was ADMP NOT MENTIONED by name in the article at all? Huge missed opportunity in some ways if I'm not mistaken about them not being mentioned by name. It was a right front page story on CNBC, still is.
WTF!
